|
AU2013263868A1
|
|
Administration of the REG1 anticoagulation system
|
|
US2014128587A1
|
|
Nucleic acid modulators of glycoprotein VI
|
|
US2014128454A1
|
|
Nucleic acid modulators of glycoprotein VI
|
|
AU2012249658A1
|
|
A method for manufacturing pegylated oligonucleotides
|
|
BRPI1011709A2
|
|
platelet nucleic acid or glycoprotein modulators vi
|
|
WO2011059459A1
|
|
Physical characterization of oligonucleotides conjugates
|
|
US2009163437A1
|
|
Steady-state subcutaneous administration of aptamers
|
|
CN101453891A
|
|
Administration of the reg1 anticoagulation system
|
|
UA94948C2
|
|
Administration of the reg1 anticoagulation system
|
|
BRPI0712473A2
|
|
administration of the anti-coagulation system reg1.
|
|
BRPI0508931A
|
|
isolated nucleic acid, pharmaceutical composition and uses of an effective amount of a first nucleic acid binder
|
